StockNews.com upgraded shares of Nathan’s Famous (NASDAQ:NATH – Free Report) from a buy rating to a strong-buy rating in a report released on Saturday morning.
Nathan’s Famous Price Performance
Shares of NATH stock opened at $69.40 on Friday. The stock’s fifty day simple moving average is $68.00 and its 200 day simple moving average is $69.44. Nathan’s Famous has a one year low of $61.35 and a one year high of $82.00. The firm has a market cap of $283.15 million, a price-to-earnings ratio of 14.43 and a beta of 0.23.
Nathan’s Famous Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, July 2nd. Investors of record on Monday, June 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date was Monday, June 24th. Nathan’s Famous’s dividend payout ratio (DPR) is currently 41.58%.
Hedge Funds Weigh In On Nathan’s Famous
Nathan’s Famous Company Profile
Nathan's Famous, Inc, together with its subsidiaries, operates in the foodservice industry. The company owns and franchises restaurants under the Nathan's Famous brand name, as well as sells products bearing the Nathan's Famous trademarks through various channels of distribution. It also has license agreements for the manufacture, distribution, marketing, and sale of Nathan's Famous branded hot dogs, sausages, and corned beef products in refrigerated consumer packages to be resold through retail channels, such as supermarkets, groceries, mass merchandisers, and club stores; and other Nathan's Famous branded refrigerated meat products in consumer packages to be resold through retail channels.
Recommended Stories
- Five stocks we like better than Nathan’s Famous
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- RXO Shares Surge Following New Acquisition Deal
- What is a Special Dividend?
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Investing in Commodities: What Are They? How to Invest in Them
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Nathan's Famous Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nathan's Famous and related companies with MarketBeat.com's FREE daily email newsletter.